These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

334 related items for PubMed ID: 16125792

  • 1. Fc receptors and their interaction with complement in autoimmunity.
    Schmidt RE, Gessner JE.
    Immunol Lett; 2005 Aug 15; 100(1):56-67. PubMed ID: 16125792
    [Abstract] [Full Text] [Related]

  • 2. Both FcgammaRIV and FcgammaRIII are essential receptors mediating type II and type III autoimmune responses via FcRgamma-LAT-dependent generation of C5a.
    Syed SN, Konrad S, Wiege K, Nieswandt B, Nimmerjahn F, Schmidt RE, Gessner JE.
    Eur J Immunol; 2009 Dec 15; 39(12):3343-56. PubMed ID: 19795417
    [Abstract] [Full Text] [Related]

  • 3. A novel interpretation of immune redundancy and duality in reperfusion injury with important implications for intervention in ischaemic disease.
    Thrane AS, Skehan JD, Thrane PS.
    Med Hypotheses; 2007 Dec 15; 68(6):1363-70. PubMed ID: 17169498
    [Abstract] [Full Text] [Related]

  • 4. New insights into the pathophysiology and in vivo function of IgG Fc receptors through gene deletion studies.
    Baumann U, Schmidt RE, Gessner JE.
    Arch Immunol Ther Exp (Warsz); 2003 Dec 15; 51(6):399-406. PubMed ID: 14692661
    [Abstract] [Full Text] [Related]

  • 5. C5a anaphylatoxin is a major regulator of activating versus inhibitory FcgammaRs in immune complex-induced lung disease.
    Shushakova N, Skokowa J, Schulman J, Baumann U, Zwirner J, Schmidt RE, Gessner JE.
    J Clin Invest; 2002 Dec 15; 110(12):1823-30. PubMed ID: 12488432
    [Abstract] [Full Text] [Related]

  • 6. The effect of activating and inhibiting Fc-receptors on murine mercury-induced autoimmunity.
    Martinsson K, Carlsson L, Kleinau S, Hultman P.
    J Autoimmun; 2008 Aug 15; 31(1):22-9. PubMed ID: 18314309
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. IgG Fc receptors.
    Ravetch JV, Bolland S.
    Annu Rev Immunol; 2001 Aug 15; 19():275-90. PubMed ID: 11244038
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. A role of FcgammaRIIB in the development of collagen-induced arthritis.
    Nakamura A, Takai T.
    Biomed Pharmacother; 2004 Jun 15; 58(5):292-8. PubMed ID: 15194165
    [Abstract] [Full Text] [Related]

  • 11. Low-affinity Fcgamma receptors, autoimmunity and infection.
    Willcocks LC, Smith KG, Clatworthy MR.
    Expert Rev Mol Med; 2009 Aug 13; 11():e24. PubMed ID: 19674504
    [Abstract] [Full Text] [Related]

  • 12. Fc receptors are major mediators of antibody based inflammation in autoimmunity.
    Hogarth PM.
    Curr Opin Immunol; 2002 Dec 13; 14(6):798-802. PubMed ID: 12413532
    [Abstract] [Full Text] [Related]

  • 13. Cell-derived anaphylatoxins as key mediators of antibody-dependent type II autoimmunity in mice.
    Kumar V, Ali SR, Konrad S, Zwirner J, Verbeek JS, Schmidt RE, Gessner JE.
    J Clin Invest; 2006 Feb 13; 116(2):512-20. PubMed ID: 16453025
    [Abstract] [Full Text] [Related]

  • 14. Complement regulatory proteins and autoimmunity.
    Song WC.
    Autoimmunity; 2006 Aug 13; 39(5):403-10. PubMed ID: 16923540
    [Abstract] [Full Text] [Related]

  • 15. Fc-receptors as regulators of immunity.
    Nimmerjahn F, Ravetch JV.
    Adv Immunol; 2007 Aug 13; 96():179-204. PubMed ID: 17981207
    [Abstract] [Full Text] [Related]

  • 16. The complement system in systemic autoimmune disease.
    Chen M, Daha MR, Kallenberg CG.
    J Autoimmun; 2010 May 13; 34(3):J276-86. PubMed ID: 20005073
    [Abstract] [Full Text] [Related]

  • 17. FcgammaRIIB as a modulator of autoimmune disease susceptibility.
    Tarasenko T, Dean JA, Bolland S.
    Autoimmunity; 2007 Sep 13; 40(6):409-17. PubMed ID: 17729034
    [Abstract] [Full Text] [Related]

  • 18. Can antibodies with specificity for soluble antigens mimic the therapeutic effects of intravenous IgG in the treatment of autoimmune disease?
    Siragam V, Brinc D, Crow AR, Song S, Freedman J, Lazarus AH.
    J Clin Invest; 2005 Jan 13; 115(1):155-60. PubMed ID: 15630455
    [Abstract] [Full Text] [Related]

  • 19. rIgG1 Fc Hexamer Inhibits Antibody-Mediated Autoimmune Disease via Effects on Complement and FcγRs.
    Spirig R, Campbell IK, Koernig S, Chen CG, Lewis BJB, Butcher R, Muir I, Taylor S, Chia J, Leong D, Simmonds J, Scotney P, Schmidt P, Fabri L, Hofmann A, Jordi M, Spycher MO, Cattepoel S, Brasseit J, Panousis C, Rowe T, Branch DR, Baz Morelli A, Käsermann F, Zuercher AW.
    J Immunol; 2018 Apr 15; 200(8):2542-2553. PubMed ID: 29531170
    [Abstract] [Full Text] [Related]

  • 20. Anti-inflammatory activity of IgG1 mediated by Fc galactosylation and association of FcγRIIB and dectin-1.
    Karsten CM, Pandey MK, Figge J, Kilchenstein R, Taylor PR, Rosas M, McDonald JU, Orr SJ, Berger M, Petzold D, Blanchard V, Winkler A, Hess C, Reid DM, Majoul IV, Strait RT, Harris NL, Köhl G, Wex E, Ludwig R, Zillikens D, Nimmerjahn F, Finkelman FD, Brown GD, Ehlers M, Köhl J.
    Nat Med; 2012 Sep 15; 18(9):1401-6. PubMed ID: 22922409
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.